Enrolling third dose level in Phase 1/2 dose escalation study of ELU001, our lead clinical program targeting solid tumors overexpressing…
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and…
AGOURA HILLS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer…
Trademark approved for “Medical alarm monitoring services for senior living in Class 45” Knoxville, Tennessee, Jan. 05, 2022 (GLOBE NEWSWIRE)…
Company announces several key U.S. Focal One installations during Q4 LYON, France, January 5, 2022 -- EDAP TMS SA (Nasdaq:…
- Dr. Shiver has contributed to the licensure of 14 pharmaceutical addressing global infectious diseases -SEATTLE, Jan. 05, 2022 (GLOBE…
Presentation at J.P. Morgan Healthcare Conference on January 13thCorporate presentation for H.C. Wainwright BioConnect Conference available online starting January 10thCompany…
CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- SalioGen Therapeutics, a privately held biotechnology company developing Gene Coding™, a new…
REDWOOD CITY, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise…
BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives…